These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7042540)

  • 1. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
    Arnon R; Sela M
    Immunol Rev; 1982; 62():5-27. PubMed ID: 7042540
    [No Abstract]   [Full Text] [Related]  

  • 2. Site-directed chemotherapy with a drug bound to anti-idiotypic antibody to a lymphoma cell-surface IgM.
    Hurwitz E; Kashi R; Burowsky D; Arnon R; Haimovich J
    Int J Cancer; 1983 Jun; 31(6):745-8. PubMed ID: 6862683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 4. Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexes.
    De Weger RA; Dullens HF; Den Otter W
    Immunol Rev; 1982; 62():28-45. PubMed ID: 7042539
    [No Abstract]   [Full Text] [Related]  

  • 5. Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin.
    Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Biochem Biophys; 1976 May; 1(4):197-202. PubMed ID: 975021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daunomycin--immunoglobulin conjugates, uptake and activity in vitro.
    Hurwitz E; Maron R; Arnon R; Wilchek M; Sela M
    Eur J Cancer (1965); 1978 Nov; 14(11):1213-20. PubMed ID: 738327
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies as carriers for oncostatic materials.
    Arnon R; Hurwitz E; Sela M
    Recent Results Cancer Res; 1980; 75():236-45. PubMed ID: 6165055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
    Hurwitz E; Levy R; Maron R; Wilchek M; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1175-81. PubMed ID: 164279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems.
    Hurwitz E; Maron R; Bernstein A; Wilchek M; Sela M; Arnon R
    Int J Cancer; 1978 Jun; 21(6):747-55. PubMed ID: 669855
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimentally developed cellular resistance to daunomycin. Resistance mechanisms, the daunomycin-pump and cross resistance to adriamycin, vincristine and vinblastine.
    Dano K
    Acta Pathol Microbiol Scand Suppl; 1976; (256 Suppl):3-80. PubMed ID: 1068629
    [No Abstract]   [Full Text] [Related]  

  • 11. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
    Schwartz HS
    Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO; Johnson DE; Ogden J; Beidler D
    Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.
    Vitetta ES; Krolick KA; Uhr JW
    Immunol Rev; 1982; 62():159-83. PubMed ID: 7042537
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytotoxic action of doxorubicin and daunomycin on human lung cancer cells].
    Potapov IuN; Krutova TV; Korman DB; Pashkova VS
    Antibiot Med Biotekhnol; 1986 Aug; 31(8):614-7. PubMed ID: 3021047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor activity of adriamycin].
    Kitaura K; Watanabe Y; Ishihara Y; Takahira H
    Jpn J Antibiot; 1972 Apr; 25(2):65-71. PubMed ID: 4341940
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation and cytotoxic properties of antibody-toxin conjugates.
    Thorpe PE; Ross WC
    Immunol Rev; 1982; 62():119-58. PubMed ID: 7042536
    [No Abstract]   [Full Text] [Related]  

  • 19. Site-directed tumor chemotherapy.
    Arnon R
    Compr Ther; 1978 Apr; 4(4):68-73. PubMed ID: 348397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
    Tsukada Y; Hurwitz E; Kashi R; Sela M; Hibi N; Hara A; Hirai H
    Ann N Y Acad Sci; 1983; 417():262-9. PubMed ID: 6200034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.